AMGN

★★☆☆☆ Passopenrouter

Amgen Inc.

Healthcare

Session move

$425.28

+$5.90+1.41%

Vol 0.90× avg

70/100 quant · tgt $387.07

RS60 +22.4% vs SPY · ADV$ 1088.1M

pushed 2026-08-19T09:38 · Pre-market · Pushed snapshot

Since last scan

2026-08-18 → 2026-08-19

Score+0.4Price+$5.90 · +1.41%Disclosure-15.0

Context only — not a buy/sell signal. Built from scan history and cached news/filings.

Snapshot quote

session 2026-08-18 · scan 2026-08-19 · pushed 2026-08-19T09:38 · Pre-market

Show quote fundamentals

Last (scan/close): $425.28
Previous close: $419.38
Pushed last: $425.28 · Pre-market
Session open: $421.64
Last session range: $420.72 – $427.39
52-week range: $264.02 – $427.39
Session volume: 2,473,976
Avg volume (20d): 2,736,184
Market cap: $229.53B
PE (TTM): 26.04
Forward PE: 17.45
Dividend yield: 2.34%
1y target est.: $387.07
Next earnings: 2026-11-03

Snapshot quote — last daily session bars and scan fundamentals. Not live bid/ask or intraday quotes. Pre/after-hours quotes are thinner and may differ from the regular session.

If you put $1,000 in

1y ago

$1,482

+48%

5y ago

$2,210

+121%

Price path only from cached daily closes (adjusted when available). Not dividends cash, fees, or advice.

Market briefing

Curated digest — not a trade signal. Headlines and links as provided by the producer.

How to Build $7,200 a Month in Dividend Income Without Selling a Single Share
Generating $86,400 a year in dividends sounds like a number reserved for the ultra-wealthy, but the capital required swings dramatically depending on one variable most investors overlook before they build a single position.
Yahoo · 2026-08-13
Reported Earlier, Amgen To Open New Science And Innovation Center At Genome Valley In Hyderabad
The center will join Amgen's global Research and Development network, which consists of seven research laboratories, further expanding the company's research and scientific capabilities. The new site reflects
Benzinga · 2026-08-12

Reddit mentions

Public Reddit titles via the official API — unofficial, delayed, not a trade signal. Not affiliated with Reddit. Opens Reddit.

No recent Reddit titles matched this ticker.

Price Chart

Daily prices from cache

Loading price history…

AI Analysis

Bull Thesis — Amgen Inc. is poised for growth with a strong EPS growth rate of 16% YoY and solid revenue growth, supported by a robust pipeline and innovative therapies in the healthcare sector.
Risks — High debt-to-equity ratio of 490.28 may pose financial risks, especially in a rising interest rate environment, potentially impacting future investments and profitability.
Target Upside — Current price of $425.28 suggests a downside to the mean target price of $387.07, indicating a potential decline of approximately 8.95%.

Score History

2026-07-3070.0 pts · 2026-08-19

15 days of scans. Daily batch adds the next weekday automatically while the API is running.

DatePriceChgScoreRating
2026-08-19$425.28+5.9070.0Pass
2026-08-18$419.38+4.1769.6Pass
2026-08-17$415.21-2.6369.6Pass
2026-08-14$417.84+1.4469.7Pass
2026-08-13$416.39+2.0969.8Pass
2026-08-12$414.30-2.9069.9Pass
2026-08-11$417.20+6.2569.9Pass
2026-08-10$410.94+6.0969.9Pass
2026-08-07$404.85-2.9869.7Pass
2026-08-06$407.83+17.8168.6Pass
2026-08-05$390.02+11.1551.0Pass
2026-08-03$378.87-6.2947.9Pass
2026-08-01$385.16+1.6547.6Pass
2026-07-31$383.51-4.1347.5Pass
2026-07-30$387.64—48.9Pass

Quant Breakdown

Revenue Growth

3.8

EPS Growth

16.0

ROE

12.0

PER Relative

5.2

Debt / Equity

0.0

FCF Margin

8.0

Analyst Upside

0.0

Insider / Sector

5.0

Momentum 3M

12.0

Earn. Surprise

8.0

Short volume (FINRA)

Off-exchange short sale volume ratio vs recent sessions — not a squeeze forecast.

as of 2026-08-18 · finra_cnms

Short / total: 34.8%
vs 20d (z): -1.90
Short vol: 343,966
Status: ok

Squeeze pressure score

full

24/100

Short leg: 11
Call leg: 51
Activity: 1.7

Call vol share: 49.1%
PCR (vol): 1.04
Call OI share: 60.6%
ATM IV: 33.2%

FINRA off-exchange short volume (TRF/ADF consolidated). Not short interest as % of float. Squeeze pressure score (0–100) — free composite of off-exchange short volume and (when available) call-side options activity. Not a probability that a squeeze will occur.

Disclosure score

Rule-based News / Insider / Earnings legs from cached SEC filings — context only, not beat/miss or a buy signal.

Disclosure score

-15

as of 2026-08-19 · mongo_cache_only

News: 0
Insider: -15
Earnings: 0

Signals below are rule hits from cached filings — Risk / Constructive / Attention. Attention is not a bullish call. Linked chips open the SEC original when available.

Risk (−)

Insider open-market sell cluster↗

Disclosure event score — rule-based view of recent SEC filings and earnings calendar. Not a prediction that price will move, and not earnings beat/miss.

Earnings surprise (quant context)

From Yahoo/public fundamentals cached on the last quant scan — not part of the disclosure event score, and not a buy signal. Figure can lag the latest print.

Last reported surprise +0.7%

Filings & events

Recent SEC disclosures and earnings dates — context only, not a trade signal.

as of 2026-08-13·sec_edgar·CIK 0000318154

Next earnings: 2026-11-03yahoo_calendar
Last earnings: —

42026-08-13
PRIMARY DOCUMENT
SEC ↗
42026-08-12
PRIMARY DOCUMENT
SEC ↗
42026-08-10
PRIMARY DOCUMENT
SEC ↗
42026-08-10
PRIMARY DOCUMENT
SEC ↗
42026-08-10
PRIMARY DOCUMENT
SEC ↗
42026-08-07
PRIMARY DOCUMENT
SEC ↗
42026-08-07
PRIMARY DOCUMENT
SEC ↗
10-Q2026-08-05
10-Q
SEC ↗
8-K2026-08-04
8-K
SEC ↗
8-K2026-07-31
8-K
SEC ↗

SEC filings as reported; earnings dates may come from Yahoo calendar. Context only — not investment advice and not a prediction that price will move on a filing or event.